TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/26 17:54 | 3/30/26 | XERS | Xeris Biopharma Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Brady James Aloysius | IL | D | S | -60 | 5.54 | 0 | -11 | -11 | 89 | D | ||||||||||||||||
10/8/25 16:32 | 10/7/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Brady James Aloysius | X0 | D | M.d | 0 | 0.00 | 0 | 72 | 0 | D | ||||||||||||||||
8/5/25 20:24 | 8/1/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Brady James Aloysius | X0 | D | M.d | 0 | 0.00 | 0 | 24 | 23 | D | ||||||||||||||||
8/5/25 20:24 | 8/1/25 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Brady James Aloysius | X0 | D | S.d | -11 | 13.14 | 0 | -1 | -3 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |